nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—urine—polycystic ovary syndrome	0.0231	0.0854	CbGeAlD
Sitaxentan—Viral diarrhoea—Metformin—polycystic ovary syndrome	0.0194	0.0968	CcSEcCtD
Sitaxentan—CYP2C9—urine—polycystic ovary syndrome	0.0179	0.0662	CbGeAlD
Sitaxentan—EDNRB—adrenal cortex—polycystic ovary syndrome	0.0173	0.0642	CbGeAlD
Sitaxentan—Sinus headache—Metformin—polycystic ovary syndrome	0.0155	0.0775	CcSEcCtD
Sitaxentan—EDNRB—endometrium—polycystic ovary syndrome	0.0155	0.0573	CbGeAlD
Sitaxentan—EDNRA—adrenal cortex—polycystic ovary syndrome	0.0143	0.053	CbGeAlD
Sitaxentan—EDNRB—uterus—polycystic ovary syndrome	0.0143	0.0528	CbGeAlD
Sitaxentan—EDNRB—pituitary gland—polycystic ovary syndrome	0.014	0.0518	CbGeAlD
Sitaxentan—EDNRB—adipose tissue—polycystic ovary syndrome	0.0139	0.0516	CbGeAlD
Sitaxentan—CYP3A4—urine—polycystic ovary syndrome	0.0136	0.0505	CbGeAlD
Sitaxentan—EDNRA—endometrium—polycystic ovary syndrome	0.0128	0.0474	CbGeAlD
Sitaxentan—EDNRB—adrenal gland—polycystic ovary syndrome	0.0125	0.0463	CbGeAlD
Sitaxentan—Tooth abscess—Metformin—polycystic ovary syndrome	0.0121	0.0605	CcSEcCtD
Sitaxentan—EDNRA—uterus—polycystic ovary syndrome	0.0118	0.0436	CbGeAlD
Sitaxentan—EDNRB—female gonad—polycystic ovary syndrome	0.0117	0.0432	CbGeAlD
Sitaxentan—EDNRB—vagina—polycystic ovary syndrome	0.0116	0.0429	CbGeAlD
Sitaxentan—EDNRA—pituitary gland—polycystic ovary syndrome	0.0116	0.0429	CbGeAlD
Sitaxentan—EDNRA—adipose tissue—polycystic ovary syndrome	0.0115	0.0427	CbGeAlD
Sitaxentan—EDNRA—adrenal gland—polycystic ovary syndrome	0.0103	0.0383	CbGeAlD
Sitaxentan—Sinus congestion—Metformin—polycystic ovary syndrome	0.0102	0.0508	CcSEcCtD
Sitaxentan—EDNRA—female gonad—polycystic ovary syndrome	0.00964	0.0357	CbGeAlD
Sitaxentan—EDNRA—vagina—polycystic ovary syndrome	0.00958	0.0355	CbGeAlD
Sitaxentan—Fungal infection—Metformin—polycystic ovary syndrome	0.00655	0.0327	CcSEcCtD
Sitaxentan—Contusion—Metformin—polycystic ovary syndrome	0.0058	0.029	CcSEcCtD
Sitaxentan—Chest discomfort—Metformin—polycystic ovary syndrome	0.00572	0.0285	CcSEcCtD
Sitaxentan—Ear pain—Metformin—polycystic ovary syndrome	0.00431	0.0215	CcSEcCtD
Sitaxentan—CYP2C19—vagina—polycystic ovary syndrome	0.00409	0.0151	CbGeAlD
Sitaxentan—Nasal congestion—Metformin—polycystic ovary syndrome	0.00403	0.0201	CcSEcCtD
Sitaxentan—Renal impairment—Metformin—polycystic ovary syndrome	0.00386	0.0193	CcSEcCtD
Sitaxentan—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00383	0.0142	CbGeAlD
Sitaxentan—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00376	0.0188	CcSEcCtD
Sitaxentan—Migraine—Metformin—polycystic ovary syndrome	0.00362	0.018	CcSEcCtD
Sitaxentan—Dehydration—Metformin—polycystic ovary syndrome	0.00342	0.0171	CcSEcCtD
Sitaxentan—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00339	0.0169	CcSEcCtD
Sitaxentan—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00336	0.0167	CcSEcCtD
Sitaxentan—Breast disorder—Metformin—polycystic ovary syndrome	0.00332	0.0166	CcSEcCtD
Sitaxentan—Cramp muscle—Metformin—polycystic ovary syndrome	0.00331	0.0165	CcSEcCtD
Sitaxentan—Angina pectoris—Metformin—polycystic ovary syndrome	0.00309	0.0154	CcSEcCtD
Sitaxentan—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00304	0.0152	CcSEcCtD
Sitaxentan—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00297	0.011	CbGeAlD
Sitaxentan—Infestation—Metformin—polycystic ovary syndrome	0.00283	0.0141	CcSEcCtD
Sitaxentan—Infestation NOS—Metformin—polycystic ovary syndrome	0.00283	0.0141	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00268	0.0134	CcSEcCtD
Sitaxentan—Bradycardia—Metformin—polycystic ovary syndrome	0.00259	0.0129	CcSEcCtD
Sitaxentan—Rhinitis—Metformin—polycystic ovary syndrome	0.00255	0.0127	CcSEcCtD
Sitaxentan—Hepatitis—Metformin—polycystic ovary syndrome	0.00254	0.0127	CcSEcCtD
Sitaxentan—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0025	0.0125	CcSEcCtD
Sitaxentan—Eye disorder—Metformin—polycystic ovary syndrome	0.00238	0.0119	CcSEcCtD
Sitaxentan—Flushing—Metformin—polycystic ovary syndrome	0.00236	0.0118	CcSEcCtD
Sitaxentan—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00236	0.0118	CcSEcCtD
Sitaxentan—Angiopathy—Metformin—polycystic ovary syndrome	0.00231	0.0115	CcSEcCtD
Sitaxentan—Immune system disorder—Metformin—polycystic ovary syndrome	0.0023	0.0115	CcSEcCtD
Sitaxentan—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00229	0.0114	CcSEcCtD
Sitaxentan—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00226	0.00838	CbGeAlD
Sitaxentan—Malnutrition—Metformin—polycystic ovary syndrome	0.00221	0.011	CcSEcCtD
Sitaxentan—Muscle spasms—Metformin—polycystic ovary syndrome	0.00213	0.0106	CcSEcCtD
Sitaxentan—Tremor—Metformin—polycystic ovary syndrome	0.00207	0.0103	CcSEcCtD
Sitaxentan—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00205	0.0102	CcSEcCtD
Sitaxentan—Malaise—Metformin—polycystic ovary syndrome	0.002	0.00996	CcSEcCtD
Sitaxentan—Chest pain—Metformin—polycystic ovary syndrome	0.00188	0.0094	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00187	0.00934	CcSEcCtD
Sitaxentan—Discomfort—Metformin—polycystic ovary syndrome	0.00186	0.00929	CcSEcCtD
Sitaxentan—Oedema—Metformin—polycystic ovary syndrome	0.00181	0.00901	CcSEcCtD
Sitaxentan—Infection—Metformin—polycystic ovary syndrome	0.00179	0.00895	CcSEcCtD
Sitaxentan—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00177	0.00884	CcSEcCtD
Sitaxentan—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00177	0.00882	CcSEcCtD
Sitaxentan—Skin disorder—Metformin—polycystic ovary syndrome	0.00175	0.00875	CcSEcCtD
Sitaxentan—Anorexia—Metformin—polycystic ovary syndrome	0.00172	0.00859	CcSEcCtD
Sitaxentan—Hypotension—Metformin—polycystic ovary syndrome	0.00169	0.00842	CcSEcCtD
Sitaxentan—Somnolence—Metformin—polycystic ovary syndrome	0.00161	0.00801	CcSEcCtD
Sitaxentan—Dyspepsia—Metformin—polycystic ovary syndrome	0.00159	0.00793	CcSEcCtD
Sitaxentan—Decreased appetite—Metformin—polycystic ovary syndrome	0.00157	0.00783	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00156	0.00778	CcSEcCtD
Sitaxentan—Fatigue—Metformin—polycystic ovary syndrome	0.00156	0.00777	CcSEcCtD
Sitaxentan—Constipation—Metformin—polycystic ovary syndrome	0.00154	0.00771	CcSEcCtD
Sitaxentan—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00149	0.00743	CcSEcCtD
Sitaxentan—Urticaria—Metformin—polycystic ovary syndrome	0.00143	0.00716	CcSEcCtD
Sitaxentan—Asthenia—Metformin—polycystic ovary syndrome	0.0013	0.00647	CcSEcCtD
Sitaxentan—Diarrhoea—Metformin—polycystic ovary syndrome	0.00124	0.00617	CcSEcCtD
Sitaxentan—Dizziness—Metformin—polycystic ovary syndrome	0.00119	0.00596	CcSEcCtD
Sitaxentan—Vomiting—Metformin—polycystic ovary syndrome	0.00115	0.00573	CcSEcCtD
Sitaxentan—Rash—Metformin—polycystic ovary syndrome	0.00114	0.00568	CcSEcCtD
Sitaxentan—Dermatitis—Metformin—polycystic ovary syndrome	0.00114	0.00568	CcSEcCtD
Sitaxentan—Headache—Metformin—polycystic ovary syndrome	0.00113	0.00565	CcSEcCtD
Sitaxentan—Nausea—Metformin—polycystic ovary syndrome	0.00107	0.00535	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000354	0.000669	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000349	0.00066	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000348	0.000656	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000344	0.00065	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000343	0.000647	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00034	0.000642	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000337	0.000636	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000335	0.000634	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000335	0.000632	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000324	0.000611	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000323	0.000611	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000323	0.00061	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000323	0.00061	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000323	0.00061	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—INSR—polycystic ovary syndrome	0.000321	0.000606	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000319	0.000602	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000317	0.000599	CbGpPWpGaD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000317	0.000599	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000316	0.000596	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000315	0.000594	CbGpPWpGaD
Sitaxentan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000311	0.000588	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FST—polycystic ovary syndrome	0.000307	0.000579	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000305	0.000576	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000305	0.000576	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000303	0.000572	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.0003	0.000567	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LHB—polycystic ovary syndrome	0.000299	0.000565	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PGR—polycystic ovary syndrome	0.000297	0.000561	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000294	0.000556	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000294	0.000556	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000293	0.000552	CbGpPWpGaD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000289	0.000546	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000283	0.000535	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000283	0.000534	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SCT—polycystic ovary syndrome	0.00028	0.00053	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00028	0.00053	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000277	0.000524	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000277	0.000523	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000277	0.000522	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000276	0.000521	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000276	0.000521	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00027	0.000511	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000268	0.000505	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000266	0.000502	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000263	0.000497	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000263	0.000497	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000261	0.000492	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00026	0.00049	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000259	0.000489	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000257	0.000485	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000257	0.000485	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000256	0.000484	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000256	0.000483	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000256	0.000483	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000256	0.000483	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000255	0.000482	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000252	0.000476	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000247	0.000466	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000245	0.000462	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000243	0.00046	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000243	0.000459	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000242	0.000456	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PRL—polycystic ovary syndrome	0.000241	0.000455	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00024	0.000453	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000235	0.000444	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000234	0.000442	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000232	0.000438	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—INSR—polycystic ovary syndrome	0.00023	0.000434	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000229	0.000433	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000229	0.000432	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000226	0.000427	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000226	0.000427	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000223	0.000421	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000223	0.000421	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000218	0.000412	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000215	0.000406	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000213	0.000403	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000213	0.000402	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PGR—polycystic ovary syndrome	0.000213	0.000401	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000212	0.0004	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00021	0.000397	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000208	0.000393	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000206	0.000389	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000203	0.000384	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000202	0.000381	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000199	0.000375	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000198	0.000374	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000198	0.000373	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000198	0.000373	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000191	0.00036	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00019	0.00036	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00019	0.000358	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00019	0.000358	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000189	0.000356	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000185	0.00035	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000184	0.000347	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000183	0.000346	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000182	0.000343	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000182	0.000343	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000181	0.000342	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00018	0.000339	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000174	0.000329	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000173	0.000327	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000173	0.000326	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PRL—polycystic ovary syndrome	0.000172	0.000326	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00017	0.000321	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000169	0.000319	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000169	0.000319	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000169	0.000318	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000169	0.000318	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000166	0.000314	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000166	0.000314	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—LEP—polycystic ovary syndrome	0.000166	0.000314	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000166	0.000313	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000166	0.000313	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000165	0.000312	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000164	0.000309	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000164	0.000309	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000154	0.000291	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000154	0.000291	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000154	0.00029	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000152	0.000286	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000151	0.000285	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000148	0.00028	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000146	0.000276	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000144	0.000273	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000144	0.000271	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000144	0.000271	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—POMC—polycystic ovary syndrome	0.000143	0.000269	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—INS—polycystic ovary syndrome	0.000142	0.000268	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000142	0.000268	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000141	0.000266	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000138	0.000261	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000137	0.000259	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000137	0.000259	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000136	0.000257	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000136	0.000257	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000134	0.000253	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000133	0.000252	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000131	0.000248	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000131	0.000248	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.00013	0.000246	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000126	0.000238	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000124	0.000234	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000121	0.000229	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.00012	0.000227	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.00012	0.000226	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LEP—polycystic ovary syndrome	0.000119	0.000225	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000114	0.000216	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.00011	0.000207	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000109	0.000206	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000109	0.000206	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000109	0.000206	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000108	0.000203	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000106	0.0002	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000105	0.000198	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000104	0.000197	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—POMC—polycystic ovary syndrome	0.000102	0.000193	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000102	0.000192	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—INS—polycystic ovary syndrome	0.000102	0.000192	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000101	0.000191	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	9.93e-05	0.000188	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF1—polycystic ovary syndrome	9.82e-05	0.000186	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.82e-05	0.000185	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT2—polycystic ovary syndrome	9.82e-05	0.000185	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	9.71e-05	0.000183	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.33e-05	0.000176	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	9.26e-05	0.000175	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.16e-05	0.000173	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.97e-05	0.000169	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.85e-05	0.000167	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.68e-05	0.000164	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	8.64e-05	0.000163	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	8.64e-05	0.000163	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	8.45e-05	0.00016	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	8.45e-05	0.000159	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.35e-05	0.000158	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	8.26e-05	0.000156	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	8e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.91e-05	0.000149	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.7e-05	0.000145	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.53e-05	0.000142	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—polycystic ovary syndrome	7.51e-05	0.000142	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	7.36e-05	0.000139	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.29e-05	0.000138	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.24e-05	0.000137	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	7.13e-05	0.000135	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	6.87e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.87e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.71e-05	0.000127	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	6.6e-05	0.000125	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.56e-05	0.000124	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.55e-05	0.000124	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	6.52e-05	0.000123	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.5e-05	0.000123	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.47e-05	0.000122	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.42e-05	0.000121	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.26e-05	0.000118	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—polycystic ovary syndrome	6.2e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	6.15e-05	0.000116	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	6.06e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	6.02e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.98e-05	0.000113	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.94e-05	0.000112	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.9e-05	0.000111	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.84e-05	0.00011	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.61e-05	0.000106	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.57e-05	0.000105	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.52e-05	0.000104	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TH—polycystic ovary syndrome	5.24e-05	9.9e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	5.1e-05	9.63e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.08e-05	9.59e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.96e-05	9.38e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.81e-05	9.08e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	4.8e-05	9.06e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.78e-05	9.03e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.65e-05	8.78e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—polycystic ovary syndrome	4.44e-05	8.38e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.42e-05	8.36e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.37e-05	8.26e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.29e-05	8.09e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	4.28e-05	8.08e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.13e-05	7.8e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	4.08e-05	7.7e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.97e-05	7.49e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.92e-05	7.4e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.9e-05	7.37e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	3.87e-05	7.3e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.72e-05	7.02e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.7e-05	6.99e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.64e-05	6.88e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.6e-05	6.81e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.52e-05	6.66e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.29e-05	6.2e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.15e-05	5.95e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.07e-05	5.79e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.92e-05	5.52e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.88e-05	5.45e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.88e-05	5.44e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.87e-05	5.41e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.66e-05	5.03e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.63e-05	4.96e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.61e-05	4.93e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.57e-05	4.86e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.45e-05	4.63e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.32e-05	4.39e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.17e-05	4.09e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.76e-05	3.32e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.73e-05	3.27e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.72e-05	3.25e-05	CbGpPWpGaD
